Veralto Earnings Call Transcripts
Fiscal Year 2026
-
The meeting covered director elections, auditor ratification, and executive compensation, with all proposals approved by shareholders. No questions were raised, and final results will be filed in a Form 8-K.
-
Q1 2026 saw 7% sales and 13% adjusted EPS growth, prompting a raised full-year EPS outlook. Strategic M&A, cost optimization, and steady end-market demand support continued momentum, with cost savings expected to ramp in 2027–2028.
Fiscal Year 2025
-
Delivered record 2025 results with 6% sales growth, double-digit adjusted EPS growth, and over $1B free cash flow. 2026 guidance targets continued core sales and margin expansion, with strong recurring revenue and new product launches supporting growth.
-
Q3 saw 6.9% sales growth, 5.1% core sales growth, and 11% adjusted EPS growth, with strong free cash flow and margin expansion. Full year guidance was raised for adjusted EPS and free cash flow conversion, with robust performance across both segments and geographies.
-
Q2 2025 delivered 4.8% core sales growth and 9.4% adjusted EPS growth, prompting a raised full-year EPS outlook. Water quality and PQI segments both saw broad-based gains, with strong free cash flow and disciplined capital allocation supporting future M&A.
-
Q1 2025 delivered strong core sales, margin, and EPS growth, with broad-based gains across segments and geographies. Tariff impacts are being mitigated through pricing, supply chain, and manufacturing actions, while full-year guidance for EPS and margins is reaffirmed.
Fiscal Year 2024
-
Delivered strong 2024 results with core sales, margin, and EPS growth above guidance, driven by broad-based segment performance and strategic M&A. 2025 outlook targets continued sales and margin growth, with disciplined capital allocation and positive end-market trends.
-
Delivered strong Q3 results with 4.6% core sales growth, 19% adjusted EPS growth, and robust margin expansion. Completed the TraceGains acquisition, raised full-year EPS guidance, and maintained a strong balance sheet while navigating headwinds in China.
-
Q2 2024 saw 3.8% core sales growth, 24% adjusted operating margin, and 6% higher adjusted EPS year-over-year. Full-year guidance was raised, with strong performance in both water quality and PQI segments, robust recurring revenue, and continued investment in growth and sustainability.